Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications

被引:0
作者
Jiannan Liu
Hao Wang
Wei Gu
Tingting Zhao
Wenxue Fan
Shaomin Peng
机构
[1] Central South University,Aier School of Ophthalmology
[2] Harbin Aier Eye Hospital,Department of Ophthalmology
[3] Aier Retina Institute,Department of Ophthalmology
[4] Beijing Aier-Intech Eye Hospital,Department of Ophthalmology
[5] Hebei Eye Hospital,Department of Ophthalmology
[6] Dongguan Aier Eye Hospital Affiliated to Jinan University,undefined
来源
International Ophthalmology | 2023年 / 43卷
关键词
YAG laser vitreolysis; Vitreous floaters; Floaters ablation; Vitreous opacities;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4585 / 4593
页数:8
相关论文
共 101 条
[1]  
Sebag J(2002)Is pharmacologic vitreolysis brewing? Retina 22 1-3
[2]  
Rheaume MA(2010)Pharmacologic vitreolysis Semin Ophthalmol 25 295-302
[3]  
Vavvas D(2011)Utility values associated with vitreous floaters Am J Ophthalmol 152 60-65-e1
[4]  
Wagle AM(2011)Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction Acta Ophthalmol 89 159-165
[5]  
Lim WY(2015)Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction Acta Ophthalmol 89 159-165
[6]  
Yap TP(2014)Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters Retina 34 1055-1061
[7]  
Neelam K(2014)Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile Retina 34 1062-1068
[8]  
Au Eong KG(2011)Safety of vitrectomy for floaters Am J Ophthalmol 151 995-998
[9]  
Schulz-Key S(2001)Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters Bull Soc Belge Ophtalmol 280 15-19
[10]  
Carlsson JO(2017)YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial JAMA Ophthalmol 135 918-923